Basic Information
| LncRNA/CircRNA Name | lncRNA-ATB |
| Synonyms | LOC109207222 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qRT-PCR, Western blot |
| Sample | ovarian cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | Downregulation of lncRNA-ATB significantly inhibited the tumorigenesis of ovarian cancer in vitro and in vivo |
| Pubmed ID | 32021299 |
| Year | 2020 |
| Title | LncRNA-ATB Promotes the Tumorigenesis of Ovarian Cancer via Targeting miR-204-3p |
External Links
| Links for lncRNA-ATB | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |